Asia Pacific Glucose Monitoring Devices
Market Report
2024
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Asia Pacific Glucose Monitoring Devices Market Report 2023.
According to Cognitive Market Research, Asia Pacific glucose monitoring devices market was valued at USD XX in 2023 and it is expected to grow at a CAGR of XX% from 2024 to 2029.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Market Split by Device Type |
|
Market Split by End User |
|
Market Split by Patient Type |
|
List of Competitors |
|
Country Analysis | China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC | Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Asia Pacific Glucose Monitoring Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Asia Pacific Glucose Monitoring Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Asia-Pacific region emerges as a key growth driver, fueled by rising healthcare expenditure, expanding middle-class population, and improving access to healthcare services. Also, diabetic patients in Japan and Australia are actively interested in the regular and timely monitoring of their glucose levels. This, along with the increasing emphasis of key players to develop their direct presence in developing countries.
In India, there are estimated 77 million people above the age of 18 years are suffering from diabetes (type 2) and nearly 25 million are prediabetics. More than 50% of people are unaware of their diabetic status which leads to health complications if not detected and treated early. Moreover, the country has significant population with high diabetes condition due to genetic predisposition, urbanization, and lifestyle changes, leading to a growing demand for continuous glucose monitoring devices.
(source https://www.who.int/india/health-topics/mobile-technology-for-preventing-ncds)
In China 2021, it was estimated that they had about 141 million diabetics aged from 20 to 79 years, which was the highest number of any country. China is having a huge demand for the glucose monitoring device due to the increased patients and for the doing the research part to cure the diabetes patients.
Furthermore, the Asia Pacific region offers significant growth opportunities for the blood glucose monitoring devices market. Rapid urbanization, changing lifestyles, and the increasing prevalence of diabetes in countries like China and India are significant drivers for market growth in the region. Additionally, the rising awareness about diabetes management and adoption of advanced technologies contribute to market expansion.
Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.
The glucose monitoring device market is marked by a number of significant players and it is competitive. For a competitive advantage, these players are implementing alliances and teamwork tactics for getting effective customers and clients for their products. Roche is one of the leading companies in the market, as it offers an extensive range of glucometers and lancets. To maintain its market position, the company focuses on expanding its product portfolio through acquisitions.
Top Companies Market Share in Asia Pacific Glucose Monitoring Devices Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The published report edition delivers Asia Pacific Market size analysis from 2019 till the forecast period of 2031. We have included analysis of top performing countries such as (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC) and their Market segmentation by Device Type, End User, Patient Type, etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.
In By type, the self-monitoring segment held the largest share of XX% in 2023. It plays a crucial role in daily diabetes management using a glucose level individually. The development and launch of a novel Self-monitoring device are anticipated to drive segment growth during the forecast period.
The continuous wearable devices segment is expected to show lucrative growth during the forecast period. Continuous wearable is a critical tool for managing Type 1 diabetes, especially in preventing severe hypoglycemia. These devices continuously monitor blood sugar levels, offering real-time readings every five minutes.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
segment analysis is key parameter for key companies and new entrants offering versatile products or services, helping them customize products to meet the need of different user scenarios. Based on the application segment analysis, key companies can choose which application segments to target in the Asia Pacific Glucose Monitoring Devices Market. Our experts continuously monitor market dynamics and consumer trends of the each application to evaluate the attractiveness and potential of each segment. In terms of revenue, we can also provide the cross split of types in the each application for year 2019-2031. To understand more please connect with our sales team.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
Hospitals and clinics held the largest share of XX% in the end user type in 2023. The use of glucose monitoring devices has increased as a result of an increase in hospital expenditures and the number of diabetes cases. These devices give medical professionals immediate answers by giving them accurate treatment plans and real data.
The home segment is becoming the most popular approach for short-term glucose monitoring worldwide. It enables people to easily check their blood sugar levels at home, whether or not they have diabetes. Based on the measured results, this method helps patients evaluate the effects of their treatment plans, which include things like nutrition, exercise, insulin, and stress reduction.
The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Asia Pacific then please revert us to access the exclusive Asia Pacific Glucose Monitoring Devices industry report Edition.
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Bio :Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical...Read More
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Asia Pacific Glucose Monitoring Devices Market is witnessing significant growth in the near future.
In 2023, the Continuous Wearable Devices segment accounted for noticeable share of Asia Pacific Glucose Monitoring Devices Market and is projected to experience significant growth in the near future.
The segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Laboratories , Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Device Type | Continuous Wearable Devices, Self-Monitoring Devices |
End User | Hospitals and Clinics, Home Care settings, Others |
Patient Type | Type 1 Diabetes, Type 2 Diabetes |
List of Competitors | Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Medtronic, Johnson & Johnson, Menarini Diagnostics S.R.L., Nipro Corp., Lifescan Inc., B. Braun SE, GE Healthcare Technologies Inc., Thermo Fisher Scientific, Insulet Corporation, Glysens Corporation, DiaMon Tech AG, Nemaura |
Chapter 1 Asia Pacific Market Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 2 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 3 Qualitative Analysis (Subject to Data Availability)
Segmentation Device Type Analysis 2019 -2031, will provide market size split by Device Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 4 Market Split by Device Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 5 Market Split by End User Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 6 Market Split by Patient Type Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Asia Pacific Glucose Monitoring Devices market
Chapter 7 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Continuous Wearable Devices have a significant impact on Asia Pacific Glucose Monitoring Devices market? |
What are the key factors affecting the Continuous Wearable Devices and Self-Monitoring Devices of Asia Pacific Glucose Monitoring Devices Market? |
What is the CAGR/Growth Rate of during the forecast period? |
By type, which segment accounted for largest share of the Asia Pacific Glucose Monitoring Devices Market? |
Which region is expected to dominate the Asia Pacific Glucose Monitoring Devices Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Asia Pacific Glucose Monitoring Devices Market
Request Sample